Navigation Links
NovaBay announces third quarter 2007 financial results
Date:11/15/2007

EMERYVILLE, CA, Nov. 15 /PRNewswire-FirstCall/ - NovaBay Pharmaceuticals, Inc. (AMEX & TSX: NBY), a biopharmaceutical company focused on developing non-antibiotic anti-infective products targeting the treatment or prevention of a wide range of bacterial and viral infections, today reported results for the third quarter ended September 30, 2007.

Net loss for the quarter ended September 30, 2007 was $1.6 million, or $0.24 per share, as compared to a net loss of $1.5 million, or $0.24 per share, for the third quarter of 2006. For the nine months ended September 30, 2007, NovaBay reported a net loss of $4.0 million, or $0.62 per share, as compared to a net loss of $4.2 million, or $0.76 per share, for the nine months ended September 30, 2006.

As of September 30, 2007, NovaBay had $6.9 million in cash, cash equivalents and investments. At September 30, 2007, there were outstanding 6,632,170 shares of common stock and 19,227,195 shares of preferred stock (which were convertible into 9,613,554 shares of common stock).

Recent Developments and Corporate Highlights:

On October 31, 2007, NovaBay completed its initial public offering of

5,000,000 shares of common stock at a price to the public of

$4.00 per share, and received net proceeds of approximately

$17.2 million after deducting underwriting discounts and commissions

of $1.4 million and other offering costs of approximately

$1.4 million. The underwriters have an option to purchase an

additional 750,000 shares of common stock until 30 days after the

closing of the IPO. Upon the closing of the IPO, all shares of

convertible preferred stock outstanding automatically converted into

9,613,554 shares of common stock. As of the closing of the initial

public offering, the Company had 21,254,474 shares of common stock

outstanding and $24.2 million in cash, cash equivalents and


'/>"/>

SOURCE NovaBay Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. NovaBay Pharmaceuticals Closes Initial Public Offering of Common Stock
2. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
3. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
4. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
5. HEI, Inc. Announces Sale of RFID Division Assets
6. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
7. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
8. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
9. Brooke Franchise Corporation Announces Selected July Results
10. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... Park Avenue Dental, a leading Florida-based dental ... top graduate of the University of Detroit School of ... website through an ultra-informative blog focused on dental tips ... the blog page is chock full of topics that ... concentrating on important dental care tips including ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 Ticket Down ... tickets in NYC. In just a week, the U.S. ... King Tennis Center. The event was originally founded in 1881 and ... Rafael Nadal was forced to withdrawal from the event because of ... women’s tournament and will return to New York City with hopes ...
(Date:8/20/2014)... Line: Less than 42 percent of women underwent ... the factors associated with foregoing reconstruction included being ... older. , Author: Monica Morrow, M.D., of the ... colleagues. , Background: The Women,s Health and Cancer ... breast reconstruction following a mastectomy. Still, most women ...
(Date:8/20/2014)... (HealthDay News) -- Pigs, hearts transplanted into baboons survived ... long as previously achieved, researchers report. The work ... animal organs to shorten transplant waiting lists. In ... into baboons, abdomens. The genetic engineering and new methods ... enabled the hearts to survive for more than a ...
(Date:8/20/2014)... HealthDay Reporter WEDNESDAY, Aug. 20, 2014 (HealthDay ... an option, but a new study shows that only about ... reasons women didn,t undergo reconstruction was that they felt it ... were focused on their cancer treatment," said lead researcher Dr. ... Cancer Center, in New York City. Also common was ...
Breaking Medicine News(10 mins):Health News:Park Avenue Dental Provides Dental Care Tips for World Wide Community on New Website Blog 2Health News:Park Avenue Dental Provides Dental Care Tips for World Wide Community on New Website Blog 3Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 2Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 3Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 4Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 5Health News:Patient perspectives on breast reconstruction following mastectomy 2Health News:Pigs' Hearts Beat for a Year in Baboons' Abdomens 2Health News:Many Women Who Have Mastectomy Don't Get Breast Reconstruction: Study 2Health News:Many Women Who Have Mastectomy Don't Get Breast Reconstruction: Study 3
... of ColdFusion Web content management solutions, today announced ... all company records, having grown an average of ... company’s average deal size increased by more than ... profitable since its inception in 1993. The company’s ...
... Edwards and breast cancer ... tough times, FERNDALE, Mich., Nov. 13 On Wednesday, ... inspiration in,life,s challenges to the Troy Hilton, at 5500 Crooks ... Parent Magazine are proud to,present this unique opportunity, entitled "An ...
... Nov. 13 Nile Therapeutics,Inc. (Nasdaq: NLTX ), ... for cardiovascular disease, today announced financial results,for the three ... operating loss for the three months ended September 30, ... $5.5 million, or $0.35 per,share, for the same period ...
... of suppressing immune response , , THURSDAY, Nov. 13 (HealthDay ... responses offers promise in efforts to develop treatments for ... a painful, inflammatory form of arthritis -- occurs when ... Foxp3 plays an important role in immune system regulation. ...
... with higher levels of phosphate in the blood are ... the coronary arteriesa key indicator of atherosclerosis and future ... 2009 issue of the Journal of the American ... represent a previously unidentified and modifiable cardiovascular risk factor, ...
... HMS Holdings Corp. (Nasdaq:,HMSY) today announced that it ... will be held November 18-19, 2008 at The New,York ... Tuesday, November 18th at 11:00 am,ET., HMS Holdings ... in,coordination of benefits and program integrity services for government,healthcare ...
Cached Medicine News:Health News: PaperThin Experiences Record Growth : Grows Revenues, Expands Channel, and Maintains 95%+ Subscription Renewal Rate 2Health News: PaperThin Experiences Record Growth : Grows Revenues, Expands Channel, and Maintains 95%+ Subscription Renewal Rate 3Health News:Elizabeth Edwards Reschedules Metro Detroit Appearance 2Health News:Nile Therapeutics, Inc. Reports 2008 Third Quarter Financial Results 2Health News:Nile Therapeutics, Inc. Reports 2008 Third Quarter Financial Results 3Health News:Nile Therapeutics, Inc. Reports 2008 Third Quarter Financial Results 4Health News:Nile Therapeutics, Inc. Reports 2008 Third Quarter Financial Results 5Health News:New Therapy Could Transform Arthritis Treatment 2Health News:High-normal phosphate levels linked to early atherosclerosis 2
(Date:8/20/2014)... Torrance Memorial Medical Center announced today ... from Covidien to provide a simple, safe and ... The acute care ventilator is designed to help ... ventilation, and help clinicians move patients off mechanical ... ventilation are often sedated to ease agitation and ...
(Date:8/20/2014)... New York , August 20, 2014 ... a new market report titled "Monochloroacetic Acid (MCA) Market ... Applications - Global Industry Analysis, Size, Share, Growth, Trends ... market was valued at USD 817.1 million in 2013 ... 2020, growing at a CAGR of 3.6% during the ...
(Date:8/20/2014)... , Aug. 20, 2014 Reportlinker.com announces ... in its catalogue: Global Coatings for ... This report analyzes the ... US$ Million by the following Product Segments: Active ... The report provides separate comprehensive analytics for the ...
Breaking Medicine Technology:Torrance Memorial Medical Center Acquires Advanced Ventilator Technology to Enhance Patient Care 2Global Monochloroacetic Acid (MCA) Market is Expected to Reach USD 1,046.7 million by 2020: Transparency Market Research 2Global Monochloroacetic Acid (MCA) Market is Expected to Reach USD 1,046.7 million by 2020: Transparency Market Research 3Global Monochloroacetic Acid (MCA) Market is Expected to Reach USD 1,046.7 million by 2020: Transparency Market Research 4Global Coatings for Medical Devices Industry 2Global Coatings for Medical Devices Industry 3Global Coatings for Medical Devices Industry 4Global Coatings for Medical Devices Industry 5Global Coatings for Medical Devices Industry 6Global Coatings for Medical Devices Industry 7Global Coatings for Medical Devices Industry 8Global Coatings for Medical Devices Industry 9Global Coatings for Medical Devices Industry 10Global Coatings for Medical Devices Industry 11Global Coatings for Medical Devices Industry 12Global Coatings for Medical Devices Industry 13Global Coatings for Medical Devices Industry 14Global Coatings for Medical Devices Industry 15Global Coatings for Medical Devices Industry 16Global Coatings for Medical Devices Industry 17Global Coatings for Medical Devices Industry 18Global Coatings for Medical Devices Industry 19Global Coatings for Medical Devices Industry 20Global Coatings for Medical Devices Industry 21
... Life Sciences, Inc. (NASDAQ: CALP ) will ... financial results at 9:00 am Eastern (6:00 am Pacific) ... Chief Executive Officer and Peter McAree, Chief Financial Officer, ... financial results and the company,s outlook for the future. ...
... 2011 Assured Pharmacy (Pink Sheets: APHYD ... to more than 3,000 sufferers of chronic pain, is ... LLP has completed an audit of Assured Pharmacy,s consolidated ...  The audited financial statements have been posted on the ...
Cached Medicine Technology:Caliper Life Sciences' First Quarter Results Conference Call Notice 2Assured Pharmacy Completes Audit of 2010 Financial Statements 2
... concave seats and large backrests with ... seats, backrests, armrests, and casters and ... for top performance in a variety ... clean room, static control, health care ...
... chairs with concave seats and large backrests ... seats, backrests, armrests, and casters and glides. ... performance in a variety of environments including: ... health care and office. • With cast ...
... Durable ergonomic chairs with concave ... support • Select options like seats, ... • Choose the BE Series for ... environments including: industry, education, laboratory, clean ...
... chairs with concave seats and large backrests ... seats, backrests, armrests, and casters and glides. ... performance in a variety of environments including: ... health care and office. • With tubular ...
Medicine Products: